More about
Childhood Brain Tumor
News
April 24, 2024
2 min read
Save
FDA grants Ojemda accelerated approval for children with advanced low-grade brain cancer
The FDA granted accelerated approval to Ojemda for the treatment of certain children with relapsed or refractory low-grade glioma.
News
November 21, 2023
3 min read
Save
Promising investigational therapy improves survival in aggressive childhood brain tumor
An international team of investigators has identified a drug candidate that nearly doubles survival rates for patients with diffuse midline glioma, an aggressive type of childhood brain tumor.